Honokiol   Click here for help

GtoPdb Ligand ID: 11610

PDB Ligand
Comment: Honokiol is a lignan that is produced by Magnolia trees that has been widely used in traditional medicine in East Asia. It has been described as having many pharmacological effects [2-5], with activities at a number of protein targets [1]. Honokiol's anti-cancer potential has been extensively investigated [3].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 0
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 40.46
Molecular weight 266.13
XLogP 5.53
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C=CCc1ccc(c(c1)c1ccc(c(c1)CC=C)O)O
Isomeric SMILES C=CCc1ccc(c(c1)c1ccc(c(c1)CC=C)O)O
InChI InChI=1S/C18H18O2/c1-3-5-13-7-9-18(20)16(11-13)14-8-10-17(19)15(12-14)6-4-2/h3-4,7-12,19-20H,1-2,5-6H2
InChI Key FVYXIJYOAGAUQK-UHFFFAOYSA-N
References
1. Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F et al.. (2019)
Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets.
Pharmacol Res, 144: 192-209. [PMID:31002949]
2. Chen C, Zhang QW, Ye Y, Lin LG. (2021)
Honokiol: A naturally occurring lignan with pleiotropic bioactivities.
Chin J Nat Med, 19 (7): 481-490. DOI: 10.1016/S1875-5364(21)60047-X [PMID:34247771]
3. Mottaghi S, Abbaszadeh H. (2022)
Natural Lignans Honokiol and Magnolol as Potential Anticarcinogenic and Anticancer Agents. A Comprehensive Mechanistic Review.
Nutr Cancer, 74 (3): 761-778. [PMID:34047218]
4. Ong CP, Lee WL, Tang YQ, Yap WH. (2019)
Honokiol: A Review of Its Anticancer Potential and Mechanisms.
Cancers (Basel), 12 (1). [PMID:31877856]
5. Pan J, Lee Y, Wang Y, You M. (2016)
Honokiol targets mitochondria to halt cancer progression and metastasis.
Mol Nutr Food Res, 60 (6): 1383-95. [PMID:27276215]
6. Schühly W, Hüfner A, Pferschy-Wenzig EM, Prettner E, Adams M, Bodensieck A, Kunert O, Oluwemimo A, Haslinger E, Bauer R. (2009)
Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.
Bioorg Med Chem, 17 (13): 4459-65. [PMID:19481465]